Key facts
- This page summarizes Morgan E. Obrien's Form 4 filing for Anterix Inc. (ATEX).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 07 Jun 2021, 18:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options Exercise
Sale
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $49.20 to $50.34. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $49.75 to $50.24. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F4
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $50.00 to $50.66. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F5
The option shares are fully vested.